Veterans Study (2026): In a large veterans cohort, SGLT2i showed lower kidney failure risk, but GLP-1 RAs were more protective in moderate-risk (KFRE) patients, while SGLT2i were superior in high-risk patients
6 Percent change from baseline to Week 72 in serum lipids
If liraglutide isnt helping you lose weight, you have options, including changing your dose or timing or switching from liraglutide to semaglutide
The peptides for weight loss overview discusses these GLP-1 mediated changes across the broader class of weight management peptides
[1] This metabolic pathway means semaglutide does not compete with the vast majority of medicationsincluding antibioticsthat are processed through hepatic enzyme systems, reducing the potential for metabolic drug interactions
In trials, tirzepatide (Zepbound for weight loss and Mounjaro for diabetes treatment) also reduced A1C better than semaglutide (Wegovy and Ozempic)